Tag Archives: Hodgkin’s lymphoma

Excellent Stem Cell Mobilization and Safety Profile for TG-0054

TaiGen Biotechnology Co., Ltd. announced today that in a phase 1 study in healthy volunteers TG-0054, a chemokine receptor CXCR4 antagonist, was well tolerated and rapidly mobilized stem cells and endothelial progenitor cells from bone marrow into peripheral blood. The number of CD34+ stem cells in circulation after one dose of TG-0054 was equal or higher than reported cell numbers needed for stem cell transplantation in cancer patients. The observed AEs were all mild and transient. A phase 2 study in stem cell transplantation for multiple myeloma, non-Hodgkin lymphoma and Hodgkin disease patients is currently being initiated (…)

“We are
Read More…

ITALY – Financing to preserve stem cells abroad

Banks are assisting families with financing so they can preserve umbilical cord stem cells that could be used to fight many diseases and malignant tumors like leukemia, neuroblastoma, and Hodgkin’s disease, and multiple myeloma. This has happened so far in Liguria and the Piedmont, where the Credito Cooperativo bank in Pianfei and Rocca de’ Baldi are present.

The project by an Italian bank in collaboration with Swiss company, Genico, calls of reduced financing rates for expenses related to the cryoconservation of umbilical cord stem cells. About 2,500 euros are needed to collect the cells, transport them to
Read More…